BCL2 and central nervous system cancer: Treatment of tumors with CNTFRα siRNA decreased the expression of p-AKT, BCL2 and Ki67, and increased the expression of cleaved Caspase 3 and BAX as observed in CNTRFα siRNA-transfected glioma in vitro (Fig. 6F).